Sangamo Therapeutics Inc banner

Sangamo Therapeutics Inc
XMUN:GBY

Watchlist Manager
Sangamo Therapeutics Inc Logo
Sangamo Therapeutics Inc
XMUN:GBY
Watchlist
Price: 0.1234 EUR Market Closed
Market Cap: €187.3m

Intrinsic Value

The intrinsic value for Sangamo Therapeutics Inc (GBY) under the Base Case is 0.1936 EUR. Compared with the current market price of 0.1234 EUR, the stock appears Undervalued by 36% .

Intrinsic value calculated using DCF
€0.1936
Other reference points

Do our valuations actually work? See backtest results .

GBY Intrinsic Value
0.1936
Undervaluation 36%
Intrinsic Value
Price €0.1234
Monitor GBY
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0.15
Get notified when the price drops into your buy zone
Intrinsic Value €0.19
Margin of Safety 20% €0.15
Current Price €0.12
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about GBY?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GBY valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sangamo Therapeutics Inc.

Explain Valuation
Alternatives to GBY

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

SGMO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one GBY stock?

The intrinsic value for Sangamo Therapeutics Inc (GBY) under the Base Case is 0.1936 EUR.

Is GBY stock undervalued or overvalued?

Compared with the current market price of 0.1234 EUR, the stock appears Undervalued by 36% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett